期刊
GENE THERAPY
卷 18, 期 11, 页码 1025-1033出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2011.58
关键词
helper adenovirus; cre recombinase; high-capacity adenovirus; tet-on system
类别
资金
- Fundacion Ramon Areces
- Fundacion MMA
- Spanish Department of Science [SAF2009-11324, BFU2007-60228, BFU2010-16382]
- UTE project CIMA
- Torres Quevedo
Standard methods for producing high-capacity adenoviral vectors (HC-Ads) are based on co-infection with a helper adenovirus (HV). To avoid HV encapsidation, its packaging signal (Psi) is flanked by recognition sequences for recombinases expressed in the producing cells. However, accumulation of HV and low yield of HC-Ad are frequently observed, due in part to insufficient recombinase expression. We describe here a novel HV (AdTetCre) in which Psi is flanked by loxP sites that can be excised by a chimeric MerCreMer recombinase encoded in the same viral genome. Efficient modulation of cleavage was obtained by simultaneous control of MerCreMer expression using a tet-on inducible system, and translocation to the nucleus by 4-hydroxytamoxifen (TAM). Encapsidation of AdTetCre was strongly inhibited by TAM plus doxycicline. Using AdTetCre and 293Cre4 cells for the production of HC-Ads, we found that cellular and virus-encoded recombinases cooperate to minimize HV contamination. The method was highly reproducible and allowed the routine production of different HC-Ads in a medium-scale laboratory setting in adherent cells, with titers >10(10) infectious units and <0.1% HV contamination. The residual HVs lacked Psi and were highly attenuated. We conclude that self-inactivating HVs based on virally encoded recombinases are promising tools for the production of HC-Ads. Gene Therapy (2011) 18, 1025-1033; doi:10.1038/gt.2011.58; published online 28 April 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据